Short-term follow-up. Survival (%) | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Nb. | First author/Ref. | Journal | Pub. year | n | Average age | % female | 1 year | 3 years | 5 years | 10 years | Country of origin |
1 | Sun YJ24 | J Clin Pharmacol | 2013 | 68 | 29 | 74% | 90.6% | 82.9% | – | – | China |
2 | Sandoval J25 | Cong Heart Dis | 2012 | 92 | 38 | 67% | – | – | 83.0% | 66.0% | Mexico |
3 | Dimopoulos K*11 | Circulation/own data | 2010 | 161 | 34 | 60% | 90.7% | 83.3% | 76.2% | – | UK |
4 | Adriaenssens T*26 | Eur Heart J | 2006 | 17 | 34 | 70% | 88.4% | 70.0% | 51.1% | – | Belgium |
5 | Callegari G27 | Monaldi Arch Chest Dis | 2004 | 47 | – | – | – | – | – | – | Italy |
6 | Oya H28 | Am Heart J | 2002 | 106 | 34 | 65% | 98.0% | – | 77.0% | 58.0% | Japan |
7 | Sandoval J29 | Am J Resp Crit Care | 2001 | 23 | 32 | 74% | 80.0% | – | – | – | Mexico |
8 | Cantor WJ8 | Am J Cardiol | 1999 | 109 | 29 | 57% | – | – | – | – | USA |
9 | Daliento L9 | Eur Heart J | 1998 | 188 | 33 | 66% | – | – | – | – | Europe |
10 | Saha A30 | Int J Cardiol | 1994 | 201 | 19 | 54% | 97.2% | – | 87.0% | 79.6% | India |
11 | Corone S15 | Arch Mal Coeur Vaiss | 1992 | 62 | – | – | – | – | – | 56.0% | France |
12 | Young D3 | Am J Cardiol | 1971 | 57 | 21 | 53% | – | – | – | – | USA |
Σ1131 | 30 | 62% |
*Only treatment naïve patients were included as part of the analysis.
Ref, Reference number; yrs, years; Σ, sum.